Momentum Stock Watch: Thermo Fisher Scientific Inc. (TMO)

Company Profile:

Thermo Fisher Scientific Inc. provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services worldwide. It is the world leader in serving science, with annual revenue exceeding $25 billion. The company was incorporated in 1956 and is headquartered in Waltham, Massachusetts.

Recent News:

For the fourth quarter of 2020, the company reported that revenue grew 54% to $10.55 billion and adjusted EPS increased 100% to $7.09. For the full year ended December 31, 2020, revenue grew 26% to $32.22 billion and adjusted EPS increased 58% to $19.55.

On January 19, 2021, the company announced it has entered into a definitive agreement to acquire Mesa Biotech, Inc., a privately held molecular diagnostic company, for approximately $450 million in cash. Under the terms of the agreement, Thermo Fisher will pay up to an additional $100 million in cash upon the completion of certain milestones following the close of the transaction.

Fundamental Analysis:

Ninestocks analyzes several different financial aspects: Growth, Profitability, solvency and efficiency.

Growth – Measures the growth of both the company’s income statement and cash flow.

@@@@@

Profitability – Measures the historical price movement of the stock.

@@@@@

Solvency – Measures the solvency of the company based on several ratios.

@@@@@

Efficiency – Measures the strength and historic growth of a company’s return on invested capital.

@@@@@

Conclusion:

TMO’s strengths can be seen in its better growth, strong profitability and better solvency compared with its peers. Its net income and reveune have increased over recently several years. Technical indicators signal the bullish signs, as there is a bullish crossover in Stochastic oscillator, the MACD is trying to cross back up and the RSI stands at 55.60 with positive bias. We rate Thermo Fisher Scientific Inc. (TMO) a STRONG BUY.